Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 2 5Phase 4 2Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 24INDUSTRY 8OTHER_GOV 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Carcinoma, Hepatocellular 9Papillomavirus Infections 4Lymphoma, Non-Hodgkin 4Hypertension, Portal 4Febrile Neutropenia 4Carcinoma, Non-Small-Cell Lung 4Polycystic Ovary Syndrome 3Ovarian Cysts 3Multiple Myeloma 3Lung Neoplasms 3Cancer Pain 3Adenomatous Polyposis Coli 3Recurrence 2Rectal Neoplasms 2Prostatic Hyperplasia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Neoplasms 2Lymphoma, B-Cell 2Lymphoma 2Liver Cirrhosis 2Leiomyoma 2Infertility 2Hyperthermia 2Hematologic Neoplasms 2Esophageal Neoplasms 2Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Surgical Wound Infection 1

Interventions

entecavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Lymphoma × Clear all
NCT02526823 2019-04-02

Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

Shandong Provincial Hospital

Phase 4 Unknown
360 enrolled
Lymphoid

Lymphoma

NCT00926757 2013-05-29

HBVNHL

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
80 enrolled
Lymphoid

Hepatitis B, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡